The Atlantic's Katherine Wu discusses what we know -- and what we are still struggling to understand -- about long Covid.
Last week the Centers for Disease Control endorsed the use of the Pfizer-BioNtech Covid vaccine in children ages five to 11. It was an announcement many families around the country had been anxiously awaiting.
Since then, about a million kids have rolled up their sleeves to receive the shot. But according to recent surveys, more than half of American parents remain hesitant. They question how safe the vaccine is, how effective it is, and whether kids, who tend to have milder cases of Covid, need it in the first place.
Apoorva Mandavilli is a reporter at the New York Times. She covers science and global health, which, for the last year and a half has meant a focus on the coronavirus pandemic, vaccinations and the government agencies managing this public health crisis. She joined Diane to answer questions about kids and vaccines.
- Apoorva Mandavilli Science and global health reporter, The New York Times
Most Recent Shows
As the war in Ukraine grinds on, a look at the economic battlefield and how the conflict might permanently reshape the global economy. Diane talks to Sebastian Mallaby, senior fellow for international economics at the Council on Foreign Relations.
David Gergen was a White House adviser to four presidents, then founded the Center for Public Leadership at Harvard. In a new book he explains what it takes to become a leader and why fresh leadership is so necessary in this country today.
Title IX turns 50 in June. Diane talks to Elizabeth Sharrow, expert on the history and consequences of the landmark sex discrimination law, about how it transformed women's sports -- and how much there is left to be done to achieve equality on the playing field.